Pretreatment with Berberine and Yohimbine protects against LPS-induced myocardial dysfunction via inhibition of cardiac I-κBα phosphorylation and apoptosis in mice

Shock

Volumn 35, Issue 3, 2011, Pages 322-328

  Wang, Yi Yang ^a   Li, Hong Mei ^a   Wang, Hua Dong ^a   Peng, Xue Mei ^b   Wang, Yan Ping ^a   Lu, Da Xiang ^a   Qi, Ren Bin ^a   Hu, Chao Feng ^a   Jiang, Jian Wei ^c  

^a Key Laboratory of State Administration of Traditional Chinese Medicine   (China)

^b First Affiliated Hospital   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

apoptosis; berberine; inhibitor of nuclear factor B ; LPS; Myocardial dysfunction; yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BERBERINE; CASPASE 3; CASPASE 7; I KAPPA B ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC DYSFUNCTION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; IN VIVO STUDY; MALE; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; PROTEIN EXPRESSION; SEPSIS; SURVIVAL RATE;

ANIMALS; APOPTOSIS; BERBERINE; ECHOCARDIOGRAPHY; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MYOCARDIUM; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA; YOHIMBINE;

EID: 79952174784     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181facf73     Document Type: Article

References (33)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001. (Pubitemid 32641789)
2. Becker JU, Theodosis C, Jacob ST, Wira CR, Groce NE: Surviving sepsis in low-income and middle-income countries: new directions for care and research. Lancet Infect Dis 9:577-582, 2009.
3. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113: 227-242, 1990. (Pubitemid 20242299)
4. Niu J, Azfer A, Kolattukudy PE: Protection against lipopolysaccharide- induced myocardial dysfunction in mice by cardiac-specific expression of soluble Fas. J Mol Cell Cardiol 44:160-169, 2008.
5. Sharma AC: Sepsis-induced myocardial dysfunction. Shock 28:265-269, 2007. (Pubitemid 47282016)
6. Rudiger A, Singer M: Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599-1608, 2007. (Pubitemid 46809326)
7. Wang X, Zingarelli B, O'Connor M, Zhang P, Adeyemo A, Kranias EG, Wang Y, Fan GC: Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappa B activation. J Mol Cell Cardiol 47:382-390, 2009.
8. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126-131, 1990. (Pubitemid 20023505)
9. Merx MW, Weber C: Sepsis and the heart. Circulation 116:793-802, 2007. (Pubitemid 47255997)
10. Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y: Cardiovascular actions of berberine. Cardiovasc Drug Rev 19:234-244, 2001. (Pubitemid 34019907)
11. Zeng XH, Zeng XJ, Li YY: Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92:173-176, 2003.
12. Yang J, Wang HD, Lu DX, Wang YP, Qi RB, Li J, Li F, Li CJ: Effects of neutral sulfate berberine on LPS-induced cardiomyocyte TNF-! secretion, abnormal calcium cycling, and cardiac dysfunction in rats. Acta Pharmacol Sin 27:173-178, 2006. (Pubitemid 43171155)
13. Zhang HQ, Wang HD, Lu DX, Qi RB, Wang YP, Yan YX, Fu YM: Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the !2-adrenergic receptor in mice. Shock 29:617-622, 2008.
14. Hui KK, Yu JL, Chan WF, Tse E: Interaction of berberine with human platelet alpha 2 adrenoceptor. Life Sci 49:315-324, 1991.
15. Semeniuk LM, Kryski AJ, Severson DL: Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 283:H976-H982, 2002.
16. You W, Min X, Zhang X, Qian B, Pang S, Ding Z, Li C, Gao X, Di R, Cheng Y, et al.: Cardiac-specific expression of heat shock protein 27 attenuated endotoxininduced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism. Shock 32:108-117, 2009.
17. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992.
18. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M: Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28:1631-1639, 1996. (Pubitemid 26300563)
19. Tatsumi T, Akashi K, Keira N, Matoba S, Mano A, Shiraishi J, Yamanaka S, Kobara M, Hibino N, Hosokawa S, et al.: Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxintreated rat hearts. J Mol Cell Cardiol 37:775-784, 2004. (Pubitemid 39194569)
20. Ben-Shaul V, Lomnitski L, Nyska A, Zurovsky Y, Bergman M, Grossman S: The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett 123:1-10, 2001. (Pubitemid 32763083)
21. Kim DW, Ahan SH, Kim TY: Enhancement of arsenic trioxide (As(2)O(3))Y mediated apoptosis using berberine in human neuroblastoma SH-SY5Y cells. J Korean Neurosurg Soc 42:392-399, 2007. (Pubitemid 350303469)
22. Haudek SB, Spencer E, Bryant DD, White DJ, Maass D, Horton JW, Chen ZJ, Giroir BP: Overexpression of cardiac I-kappa B alpha prevents endotoxininducedmyocardial dysfunction. Am J Physiol Heart Circ Physiol 280:H962-H968, 2001.
23. Baumgarten G, Knuefermann P, Nozaki N, Sivasubramanian N, Mann DL, Vallejo JG: In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of Toll-like receptor-4. J Infect Dis 183:1617-1624, 2001. (Pubitemid 32466699)
24. Lancel S, Joulin O, Favory R, Goossens JF, Kluza J, Chopin C, Formstecher P, Marchetti P, Neviere R: Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111:2596-2604, 2005. (Pubitemid 40740858)
25. Brown MA, Jones WK: NF-kappa B action in sepsis: the innate immune system and the heart. Front Biosci 9:1201-1217, 2004. (Pubitemid 39060836)
26. Haudek SB, Spencer E, Bryant DD, White DJ, Maass D, Horton JW, Chen ZJ, Giroir BP: Overexpression of cardiac I-.B! prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 280:H962-H968, 2001.
27. Barki-Harrington L, Perrino C, Rockman HA: Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc Res 63:391-402, 2004. (Pubitemid 38970183)
28. Kang BY, Chung SW, Cho D, Kim TS: Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochem Pharmacol 63:1901-1910, 2002. (Pubitemid 34603455)
29. Zhou M, Yang S, Koo DJ, Ornan DA, Chaudry IH, Wang P: The role of Kupffer cell alpha (2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim Biophys Acta 1537:49-57, 2001. (Pubitemid 32710039)
30. Miksa M, Das P, Zhou M, Wu R, Dong W, Ji Y, Goyert SM, Ravikumar TS, Wang P: Pivotal role of the alpha (2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS One 4:e5504, 2009.
31. Davani EY, Boyd JH, Dorscheid DR, Wang Y, Meredith A, Chau E, Singhera GK, Walley KR: Cardiac ICAM-1 mediates leukocyte-dependent decreased ventricular contractility in endotoxemic mice. Cardiovasc Res 72:134-142, 2006. (Pubitemid 44310639)
32. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R: Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241-247, 2000. (Pubitemid 30626433)
33. Jozefowicz E, Brisson H, Rozenberg S, Mebazaa A, Gelé P, Callebert J, Lebuffe G, Vallet B, Bordet R, Tavernier B: Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats. Crit Care Med 35:856-863, 2007. (Pubitemid 46407802)